ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Ascletis Receives IND Approval for its HIV Drug ASC09F prnasia
April 13, 2020Ascletis Pharma Inc. (HKEX code: 1672) announces today that it received IND approval from National Medical Products Administration (NMPA) for its human immunodeficiency virus (HIV) protease inhibitor ASC09F (ASC09/Ritonavir Fixed-Dose Combination).
Pharma Sources Insight January 2025
